Preclinical evaluation of [ 111 In]-DOTA-trastuzumab for clinical trials

AmirReza Jalilian, Mohammad Mirzaii, Gholamreza Aslani, Saeed Rajabifar, Sedigheh Moradkhani, Mehraban Pouladi, Behrouz Alirezapour
  • Journal of Cancer Research and Therapeutics, January 2014, Medknow
  • DOI: 10.4103/0973-1482.131434

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

The following have contributed to this page: Prof Amir R Jalilian